Overview

• Traumagel can stop bleeding in seconds without applying pressure, unlike traditional methods.
• The gel will be available in pre-filled syringes for easy application by emergency services and military.
• FDA clearance was based on pre-clinical data showing its effectiveness compared to standard treatments.
• Cresilon plans to launch Traumagel in late 2024, pricing it competitively with existing options.
• About 40% of trauma-related deaths globally are due to bleeding, highlighting the gel's potential impact.